Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telomerase in human bladder cancer.

B C Liu1, K R Loughlin

  • 1Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. DrLiu@aol.com

The Urologic Clinics of North America
|March 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinicopathologic features and treatment of 13 cases of Castleman's disease].

Zhonghua nei ke za zhi·2026
Same author

[Identify the factors associated with treatment-free remission outcomes after imatinib discontinuation in children and adolescent patients with chronic myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

[A case of xanthogranulomatous pyelonephritis associated with immunological abnormality and severe pulmonary infection].

Zhonghua nei ke za zhi·2025
Same author

[Immunorelated Stevens-Johnson syndrome/toxic epidermolysis caused by programmed death receptor 1 inhibitors: a case report].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2025
Same author

[Clinical analysis of seven cases of primary hyperoxaluria type 1].

Zhonghua nei ke za zhi·2024
Same author

[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Researchers reviewed telomerase activity as a potential biomarker for human bladder cancer detection. This enzyme

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Current human bladder cancer biomarkers are insufficient for noninvasive diagnosis.
  • Achieving consistent, noninvasive diagnosis remains a significant challenge in bladder cancer management.

Purpose of the Study:

  • To review the potential applications of telomerase in human bladder cancer.
  • To explore telomerase's role in diagnosis, monitoring, and treatment.

Main Methods:

  • Literature review on telomerase function and its relation to cancer.
  • Analysis of existing studies on telomerase activity in bladder cancer.

Main Results:

  • Telomerase activity is linked to maintaining telomere length.
  • Elevated telomerase activity may indicate the presence of immortal or cancerous cells.

Related Experiment Videos

Conclusions:

  • Telomerase presents a promising avenue for noninvasive bladder cancer diagnosis.
  • Further research into telomerase applications could improve bladder cancer monitoring and treatment strategies.